Ratings by Goldman Sachs (Salveen Richter)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/26/2026 | Seaport Therapeutics | SPTX | New Coverage | Early-Stage Biotech (N/A) |
17.19 (20.10) |
16.93% | Details | |
| 5/12/2026 | Annexon Biosciences | ANNX | New Coverage | Neutral (N/A) |
5.68 (5.63) |
-0.88% | Details | |
| 5/11/2026 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Neutral (N/A) |
54.06 (59.20) |
9.51% | Details | |
| 5/8/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2026 | Moderna | MRNA | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2026 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Intellia Therapeutics | NTLA | Maintain | Sell (N/A) |
|
Details | ||
| 4/20/2026 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 4/1/2026 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 3/25/2026 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 3/24/2026 | Ultragenyx Pharma | RARE | Downgrade | Neutral (Buy) |
19.87 (33.22) |
67.19% | Details | |
| 3/24/2026 | Generate Biomedicines | GENB | New Coverage | Buy (N/A) |
12.27 (14.28) |
16.38% | Details | |
| 3/3/2026 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2026 | Intellia Therapeutics | NTLA | Maintain | Sell (N/A) |
|
Details | ||
| 2/26/2026 | Intellia Therapeutics | NTLA | Maintain | Sell (N/A) |
|
Details | ||
| 2/17/2026 | Moderna | MRNA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2026 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2026 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Apellis Pharmaceuticals | APLS | Maintain | Sell (N/A) |
|
Details | ||
| 1/12/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Incyte | INCY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/9/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2025 | Taysha Gene Therapies | TSHA | Upgrade | Buy (Early-Stage Biotech) |
4.49 (5.38) |
19.82% | Details | |
| 11/25/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Prime Medicine | PRME | Maintain | Early-Stage Biotech (N/A) |
|
Details | ||
| 9/29/2025 | Ionis Pharmaceuticals | IONS | Maintain | Neutral (N/A) |
|
Details | ||
| 9/29/2025 | Apellis Pharmaceuticals | APLS | Maintain | Sell (N/A) |
|
Details | ||
| 9/26/2025 | Apellis Pharmaceuticals | APLS | Downgrade | Sell (Neutral) |
22.22 (41.03) |
84.65% | Details | |
| 9/26/2025 | Ionis Pharmaceuticals | IONS | Upgrade | Neutral (Sell) |
62.97 (56.75) |
-9.88% | Details | |
| 9/25/2025 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 9/22/2025 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
9.39 (22.80) |
142.81% | Details | |
| 9/5/2025 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Apogee Therapeutics Inc | APGE | Maintain | Early-Stage Biotech (N/A) |
|
Details | ||
| 8/11/2025 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2025 | Sarepta Therapeutics | SRPT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/10/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 6/26/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Sell (N/A) |
|
Details | ||
| 6/17/2025 | Sarepta Therapeutics | SRPT | Downgrade | Neutral (Buy) |
20.94 (18.82) |
-10.12% | Details | |
| 6/16/2025 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
21.91 (50.87) |
132.18% | Details | |
| 5/28/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2025 | Intellia Therapeutics | NTLA | Maintain | Sell (N/A) |
|
Details | ||
| 3/3/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2025 | Intellia Therapeutics | NTLA | Downgrade | Sell (Neutral) |
10.86 (13.02) |
19.89% | Details | |
| 2/28/2025 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/26/2025 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/4/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Moderna | MRNA | Downgrade | Neutral (Buy) |
41.65 (67.01) |
60.89% | Details | |
| 1/28/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2025 | Intellia Therapeutics | NTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 1/14/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2025 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2025 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2024 | Apellis Pharmaceuticals | APLS | Downgrade | Neutral (Buy) |
33.66 (22.22) |
-33.99% | Details | |
| 12/11/2024 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/12/2024 | 2Seventy Bio Inc. | TSVT | Maintain | Sell (N/A) |
|
Details | ||
| 11/8/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Incyte | INCY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2024 | Intellia Therapeutics | NTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2024 | Amgen | AMGN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 10/10/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Incyte | INCY | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2024 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 9/10/2024 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
6.24 (18.73) |
200.16% | Details | |
| 9/3/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | Alnylam Pharmaceuticals | ALNY | Upgrade | Buy (Neutral) |
262.70 (288.06) |
9.65% | Details | |
| 8/8/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 8/2/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2024 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 7/17/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2024 | 2Seventy Bio Inc. | TSVT | Downgrade | Sell (Neutral) |
4.56 (5.00) |
9.65% | Details | |
| 6/6/2024 | Ultragenyx Pharma | RARE | Upgrade | Buy (Neutral) |
40.92 (19.87) |
-51.44% | Details | |
| 6/4/2024 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2024 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2024 | uniQure BV | QURE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2024 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 5/6/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2024 | Amgen | AMGN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 4/26/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 4/25/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/28/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | bluebird bio | BLUE | Maintain | Sell (N/A) |
|
Details | ||
| 2/29/2024 | uniQure BV | QURE | Downgrade | Neutral (Buy) |
6.69 (41.10) |
514.35% | Details | |
| 2/29/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Intellia Therapeutics | NTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2024 | Intellia Therapeutics | NTLA | Downgrade | Neutral (Buy) |
27.18 (13.02) |
-52.1% | Details | |
| 2/16/2024 | Alnylam Pharmaceuticals | ALNY | Downgrade | Neutral (Buy) |
147.43 (262.70) |
78.19% | Details | |
| 2/16/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | 4D Molecular Therapeutics | FDMT | New Coverage | Buy (N/A) |
32.29 (11.30) |
-65% | Details | |
| 1/31/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2023 | Vertex | VRTX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 11/21/2023 | Incyte | INCY | Downgrade | Neutral (Buy) |
54.71 (114.23) |
108.79% | Details | |
| 11/10/2023 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
46.99 (33.66) |
-28.37% | Details | |
| 11/8/2023 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 11/3/2023 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/2/2023 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2023 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 9/13/2023 | 2Seventy Bio Inc. | TSVT | Downgrade | Neutral (Buy) |
4.16 (4.56) |
9.62% | Details | |
| 8/15/2023 | 2Seventy Bio Inc. | TSVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
16.75 (8.68) |
-48.18% | Details | |
| 8/3/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Sell (N/A) |
|
Details | ||
| 5/9/2023 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Agios Pharma | AGIO | Upgrade | Neutral (Buy) |
28.41 (40.55) |
42.73% | Details | |
| 11/15/2022 | 4D Molecular Therapeutics | FDMT | Upgrade | Buy (Neutral) |
13.49 (32.29) |
139.36% | Details | |
| 11/14/2022 | Prime Medicine | PRME | New Coverage | Neutral (N/A) |
20.57 (3.52) |
-82.89% | Details | |
| 11/11/2022 | Lyell Immunopharma | LYEL | Downgrade | Neutral (Buy) |
4.96 (14.33) |
188.91% | Details | |
| 11/10/2022 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | Taysha Gene Therapies | TSHA | Downgrade | Neutral (Buy) |
2.20 (4.49) |
104.09% | Details | |
| 11/9/2022 | Recursion Pharmaceuticals | RXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2022 | Acadia Pharmaceuticals | ACAD | Downgrade | Sell (Neutral) |
15.93 (25.50) |
60.08% | Details | |
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Sana Biotechnology | SANA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Vertex | VRTX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 10/28/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | Biogen | BIIB | Upgrade | Buy (Neutral) |
273.56 (209.03) |
-23.59% | Details | |
| 10/13/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | bluebird bio | BLUE | Maintain | Sell (N/A) |
|
Details | ||
| 9/8/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2022 | bluebird bio | BLUE | Maintain | Sell (N/A) |
|
Details | ||
| 8/12/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Recursion Pharmaceuticals | RXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
71.70 (27.18) |
-62.09% | Details | |
| 7/29/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2022 | Allogene | ALLO | Upgrade | Buy (Neutral) |
12.24 (1.93) |
-84.23% | Details | |
| 6/21/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2022 | 2Seventy Bio Inc. | TSVT | New Coverage | Buy (N/A) |
14.25 (4.16) |
-70.81% | Details | |
| 4/13/2022 | Amicus Therapeutics | FOLD | New Coverage | Neutral (N/A) |
8.38 (14.49) |
72.91% | Details | |
| 3/31/2022 | Vertex | VRTX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 2/25/2022 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 2/25/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Allogene | ALLO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/17/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Reata Pharmaceuticals | RETA | Downgrade | Neutral (Buy) |
54.42 (37.09) |
-31.84% | Details | |
| 12/7/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2021 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
628.73 (663.09) |
5.46% | Details | |
| 12/6/2021 | Amgen | AMGN | New Coverage | Buy (N/A) |
202.44 (360.45) |
78.05% | Details | |
| 12/6/2021 | Gilead Sciences | GILD | New Coverage | Neutral (N/A) |
69.56 (131.40) |
88.9% | Details | |
| 12/6/2021 | Biogen | BIIB | New Coverage | Neutral (N/A) |
223.92 (209.03) |
-6.65% | Details | |
| 11/24/2021 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Buy (Neutral) |
181.00 (288.06) |
59.15% | Details | |
| 11/8/2021 | bluebird bio | BLUE | Downgrade | Sell (Neutral) |
13.14 (4.97) |
-62.18% | Details | |
| 11/5/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/7/2021 | Allogene | ALLO | Downgrade | Neutral (Buy) |
23.97 (1.93) |
-91.95% | Details | |
| 9/21/2021 | Seagen | SGEN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/24/2021 | Omega Therapeutics | OMGA | New Coverage | Neutral (N/A) |
21.83 (0.14) |
-99.36% | Details | |
| 8/20/2021 | Intercept Pharmaceuticals | ICPT | Downgrade | Sell (Neutral) |
14.22 (19.00) |
33.61% | Details | |
| 8/10/2021 | bluebird bio | BLUE | Downgrade | Neutral (Buy) |
18.16 (13.14) |
-27.64% | Details | |
| 8/6/2021 | Sana Biotechnology | SANA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | Agios Pharma | AGIO | Downgrade | Sell (Neutral) |
49.84 (40.55) |
-18.64% | Details | |
| 7/29/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2021 | Lyell Immunopharma | LYEL | New Coverage | Buy (N/A) |
15.25 (14.33) |
-6.03% | Details | |
| 6/24/2021 | TCR2 Therapeutics | TCRR | New Coverage | Buy (N/A) |
17.24 (1.48) |
-91.42% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (40.50) |
62.59% | Details | |
| 5/24/2021 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
111.60 (54.42) |
-51.24% | Details | |
| 5/20/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/11/2021 | Recursion Pharmaceuticals | RXRX | New Coverage | Neutral (N/A) |
27.73 (3.30) |
-88.1% | Details | |
| 5/10/2021 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2021 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
55.78 (49.84) |
-10.65% | Details | |
| 4/29/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
25.59 (25.50) |
-0.35% | Details | |
| 3/28/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/25/2021 | Sana Biotechnology | SANA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/18/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2021 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2021 | Passage Bio Inc. | PASG | Upgrade | Buy (Neutral) |
19.59 (4.46) |
-77.23% | Details | |
| 3/3/2021 | Adeptus Biotechnologies Corp. | ADPT | Downgrade | Neutral (Buy) |
53.11 (4.95) |
-90.68% | Details | |
| 3/2/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Sana Biotechnology | SANA | New Coverage | Neutral (N/A) |
32.05 (3.64) |
-88.64% | Details | |
| 2/26/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/17/2020 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Cellectis | CLLS | Maintain | Sell (N/A) |
|
Details | ||
| 11/6/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/19/2020 | Taysha Gene Therapies | TSHA | New Coverage | Neutral (N/A) |
21.05 (5.38) |
-74.44% | Details | |
| 10/16/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2020 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
22.45 (13.02) |
-42% | Details | |
| 9/8/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/13/2020 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2020 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
41.02 (6.24) |
-84.79% | Details | |
| 8/6/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
77.49 (19.00) |
-75.48% | Details | |
| 6/25/2020 | Passage Bio Inc. | PASG | Downgrade | Neutral (Buy) |
36.07 (4.46) |
-87.64% | Details | |
| 6/3/2020 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
39.07 (21.02) |
-46.2% | Details | |
| 6/1/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | Incyte | INCY | Downgrade | Buy (Conviction Buy) |
99.37 (114.23) |
14.95% | Details | |
| 5/26/2020 | Seattle Genetics | SGEN | Upgrade | Conviction Buy (Buy) |
155.77 (228.74) |
46.84% | Details | |
| 5/18/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Arrowhead Research | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2020 | Mirati Therapeutics | MRTX | New Coverage | Buy (N/A) |
85.32 (58.70) |
-31.2% | Details | |
| 4/3/2020 | Precision BioSciences Inc. | DTIL | Downgrade | Neutral (Buy) |
5.27 (8.59) |
63% | Details | |
| 3/31/2020 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
38.83 (25.59) |
-34.1% | Details | |
| 3/26/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2020 | Arrowhead Research | ARWR | New Coverage | Neutral (N/A) |
26.32 (74.11) |
181.57% | Details | |
| 3/6/2020 | Cellectis | CLLS | Downgrade | Sell (Neutral) |
15.74 (2.90) |
-81.58% | Details | |
| 2/28/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/14/2020 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/11/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/27/2020 | Denali Therapeutics Inc. | DNLI | Upgrade | Buy (Neutral) |
24.90 (26.48) |
6.35% | Details | |
| 1/3/2020 | Incyte | INCY | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 12/24/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | uniQure BV | QURE | New Coverage | Buy (N/A) |
54.78 (6.69) |
-87.79% | Details | |
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2019 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2019 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Solid Biosciences | SLDB | Maintain | Sell (N/A) |
|
Details | ||
| 11/11/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 9/27/2019 | Atara Biotherapeutics | ATRA | Downgrade | Sell (Neutral) |
14.29 (8.67) |
-39.33% | Details | |
| 9/27/2019 | Seattle Genetics | SGEN | Upgrade | Buy (Conviction Sell) |
73.62 (155.77) |
111.59% | Details | |
| 9/3/2019 | Vertex | VRTX | Upgrade | Conviction Buy (Buy) |
180.02 (480.25) |
166.78% | Details | |
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2019 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
19.69 (329.83) |
1575.11% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Neutral (N/A) |
128.80 (182.01) |
41.31% | Details | |
| 5/23/2019 | Vertex | VRTX | New Coverage | Buy (N/A) |
169.12 (180.02) |
6.45% | Details | |
| 5/23/2019 | Alnylam Pharmaceuticals | ALNY | New Coverage | Neutral (N/A) |
67.87 (288.06) |
324.43% | Details | |
| 5/23/2019 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
51.36 (40.55) |
-21.05% | Details | |
| 5/23/2019 | Blueprint Medicines | BPMC | New Coverage | Buy (N/A) |
78.97 (129.46) |
63.94% | Details | |
| 5/14/2019 | Solid Biosciences | SLDB | Downgrade | Sell (Neutral) |
8.85 (9.72) |
9.83% | Details | |
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
12.18 (5.27) |
-56.73% | Details | |
| 1/28/2019 | CRISPR Therapeutics | CRSP | Downgrade | Neutral (Buy) |
32.29 (50.63) |
56.8% | Details | |
| 1/15/2019 | Incyte | INCY | Upgrade | Conviction Buy (Buy) |
74.65 (99.37) |
33.11% | Details | |
| 1/2/2019 | Moderna | MRNA | New Coverage | Buy (N/A) |
15.27 (41.65) |
172.76% | Details | |
| 12/26/2018 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 12/19/2018 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
17.71 (15.74) |
-11.12% | Details | |
| 12/11/2018 | Acorda Therapeutics, Inc. | ACOR | Downgrade | Sell (Neutral) |
18.63 (0.66) |
-96.46% | Details | |
| 11/5/2018 | Allogene | ALLO | New Coverage | Buy (N/A) |
26.95 (1.93) |
-92.84% | Details | |
| 9/21/2018 | bluebird bio | BLUE | Downgrade | Buy (Conviction Buy) |
141.30 (18.16) |
-87.15% | Details | |
| 9/19/2018 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 8/28/2018 | Ionis Pharmaceuticals | IONS | Maintain | Sell (Sell) |
|
Details |
